TOPICAINE

Product NDC: 63135-312
11-digit product format: 631350312
Labeler code: 63135
Product ID: 63135-312_47e8cec4-fde0-1956-e063-6394a90a1bdc
Type: HUMAN OTC DRUG
Nonproprietary name: LIDOCAINE 4%
Dosage form: GEL
Route: TOPICAL
Labeler: ESBA LABORATORIES INC.
Application: M017
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2003-04-20
Substance: LIDOCAINE
Active strength: 4 g/100g
Pharmacologic classes: Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	63135-312		D	Discontinued by firm	2026-10-21
excluded package	package	63135-312	63135-312-04	D	Discontinued by firm	2026-10-21
excluded package	package	63135-312	63135-312-13	D	Discontinued by firm	2026-10-21
excluded package	package	63135-312	63135-312-30	D	Discontinued by firm	2026-10-21

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 64 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63135-312-30	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63135-312-13	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63135-312-04	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63135-312-30	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63135-312-13	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63135-312-04	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63135-312-30	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63135-312-13	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63135-312-04	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63135-312-30	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63135-312-13	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63135-312-04	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63135-312-30	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63135-312-13	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63135-312-04	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63135-312-30	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63135-312-13	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63135-312-04	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63135-312-30	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63135-312-13	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63135-312-04	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63135-312-30	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63135-312-13	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63135-312-04	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63135-312-30	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63135-312-13	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63135-312-04	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63135-312-30	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63135-312-13	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63135-312-04	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63135-312-30	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63135-312-13	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63135-312-04	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63135-312-13	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63135-312-30	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63135-312-30	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63135-312-04	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63135-312-13	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63135-312-04	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	63135-312-13	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	63135-312-30	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	63135-312-04	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	63135-312-13	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	63135-312-30	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	63135-312-04	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: TOPICAINE
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LIDOCAINE	4 g/100g

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
98PI200987	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1291672	Internal RxNorm lookup
1651001	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
7f96e980-891e-743d-e053-2a91aa0aea5f	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
070fbed5-7088-434a-a7ce-f2a64d8d40ac	Product name	2	20260107
bee66ce1-adb7-9d3b-67d9-582e4c54e80f	Product name	5	20250819
860a93dc-4863-49cc-b284-6bbe8191bc48	Product name	4	20250214
eaba870a-6a9d-442e-8643-87b3f558a451	Product name	1	20250117
777d68c6-a5ab-e06c-d314-677b0b9af0c8	Product name	2	20240508
9b4cf230-fd05-41d5-98c6-5db9ecb27b86	Product name	1	20230117
7d755fa1-1087-4dcd-98f0-6d4bba479a57	Product name	3	20210602
aed701d5-9c75-dfaf-7154-cde46179faea	Product name	9	20200313
fa8b5901-e681-426f-82fe-54f6d81ec698	Product name	4	20180619
332d03e4-aa24-4b11-841a-02bf41081920	Product name	1	20171221
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070	Product name	1	20171221
68ed98f8-24c2-44a0-944a-6d36e82ce25a	Product name	1	20141222
1cd42bc2-a430-c72b-636d-991b235fbf80	Product name	1	20140508
49fa150c-f0de-cce7-3d9c-993ed81c5698	Product name	1	20140508
4d7ae718-ed00-bae8-2abe-9eaec1eef7ff	Product name	1	20140508
9137811f-f279-8640-5aeb-99fa2145d64d	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
63135-312-04	2024-09-21	TOPICAINE
63135-312-04	2024-09-21	TOPICAINE
63135-312-13	2024-09-21	TOPICAINE
63135-312-13	2024-09-21	TOPICAINE
63135-312-30	2024-09-21	TOPICAINE
63135-312-30	2024-09-21	TOPICAINE
63135-312-04	2023-01-30	TOPICAINE
63135-312-04	2023-01-30	TOPICAINE
63135-312-13	2023-01-30	TOPICAINE
63135-312-13	2023-01-30	TOPICAINE
63135-312-30	2023-01-30	TOPICAINE
63135-312-30	2023-01-30	TOPICAINE

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
63135-312-04	TOPICAINE	113 g in 1 TUBE	GEL	113	5
63135-312-13	TOPICAINE	10 g in 1 TUBE	GEL	10	5
63135-312-13	TOPICAINE	1 in 1 BOX	GEL	1	5
63135-312-30	TOPICAINE	1 in 1 BOX	GEL	1	5
63135-312-30	TOPICAINE	30 g in 1 TUBE	GEL	30	5

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63135-312-04	GM - Gram	63135-312	477107f9-14e6-49b4-9bc3-5ba2f4b06dfc	1	2015-06-09
63135-312-13	GM - Gram	63135-312	4683b683-a1f1-476f-ba81-ec4e7d0df609	1	2015-06-09
63135-312-30	GM - Gram	63135-312	7cd93361-2de8-46e6-8d3e-cefdcf7482c7	1	2015-06-09

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63135-312	TOPICAINE (LIDOCAINE 4%) GEL [ESBA LABORATORIES INC.]	4	Current NDC, Legacy NDC, 5 package rows	20240922_7f96e980-891e-743d-e053-2a91aa0aea5f.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 83 of 152 · 3,029 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Chimera GUARD	LIDOCAINE PAIN RELIEFING PATCH	Hangzhou Rongna Health Technology Co., Ltd.	3758d625-010f-7441-e063-6394a90a066d	2025-07-29	Warnings	Exact identifier application number: M017
Cold Therapy Roll on	COLD THERAPY ROLL ON	Allegiant Health	36463acb-7c28-416f-a45f-a93f0be5692b	2025-07-29	Warnings	Exact identifier application number: M017
ProCure Anti Itch	CAMPHOR 0.5%	Twin Med LLC	3afe387c-ef42-215d-e063-6394a90a41b5	2025-07-28	Warnings	Exact identifier application number: M017
lidocaine pain relief patches	LIDOCAINE	Changsha Maocheng Trading Co., Ltd	3afeead3-4f5c-4711-e063-6294a90aacca	2025-07-28	Warnings	Exact identifier application number: M017
SYNC ICE	SYNC RELIEF ICE	iON Pharma, LLC	38ce98ce-a7bf-8041-e063-6394a90ae730	2025-07-28	Warnings	Exact identifier application number: M017
SYNC PRO	SYNC RELIEF PRO CREAM	iON Pharma, LLC	3a3e91d6-732b-dca9-e063-6394a90a06d4	2025-07-28	Warnings	Exact identifier application number: M017
Careland Pain Relief	METHYL SALICYLATE, MENTHOL	Planet (Anhui) Pharmaceutical Co., Ltd.	83f36771-1033-4fd0-a0e6-82c1dcfedeee	2025-07-28	Warnings	Exact identifier application number: M017
Rite Aid anti-itch	HYDROCORTISONE	Rite Aid Corporation	2a232dd1-9071-4c55-a7f7-19d8404b99a6	2025-07-28	Warnings	Exact identifier application number: M017
Hydrocortisone Plus 12 Moisturizers	HYDROCORTISONE	RITE AID CORPORATION	05598255-3e7a-46a5-ae7e-dcfcb616d59d	2025-07-28	Warnings	Exact identifier application number: M017
Inked Inspired	LIDOCAINE HCL	Prodigy Media Inc	54fb2860-7e63-4598-953a-170226e613e9	2025-07-28	Warnings	Exact identifier application number: M017
Ujhay Hydrocortisone Ointment.	UJHAY HYDROCORTISONE OINTMENT	Guangdong Quadrant Ecological Technology Co., Ltd.	3af59276-8e6a-0603-e063-6394a90a1f9b	2025-07-27	Warnings	Exact identifier application number: M017
SANA SANA Menthol External Analgesic	MENTHOL	Alquimia Najulam S de RL de CV	8b7edd51-e08a-4e01-9df0-8305ce17b418	2025-07-25	Warnings	Exact identifier application number: M017
Hydrocortisone Intensive Healing Formula	HYDROCORTISONE	TARGET Corporation	682b737f-e453-4079-bf31-47a9485c7897	2025-07-25	Warnings	Exact identifier application number: M017
Chigg Away	BENZOCAINE	Pierson Laboratories, Inc.	8372e7c1-f145-4bc5-85ab-cf831abe70ce	2025-07-24	Warnings	Exact identifier application number: M017
Chigg Away	BENZOCAINE	Pharma Nobis, LLC	e42fa1c6-d804-630f-e053-2995a90add6b	2025-07-24	Warnings	Exact identifier application number: M017
Cannarelief 2000mg	MENTHOL	Earthmed LLC	01f810de-52ba-8beb-e063-6394a90a61c0	2025-07-24	Warnings	Exact identifier application number: M017
CHING WAN HUNG SOOTHING HERBAL BALM	MENTHOL	TIANJIN DARENTANG JINGWANHONG PHARMACEUTICAL CO., LTD.	ffadc904-8e9d-4cb8-815a-d583bbdb3f0b	2025-07-24	Warnings	Exact identifier application number: M017
PT Elite Premium Pain Relief	CAPSAICIN, MENTHOL	PT ELITE PRODUCTS LLC	ad251821-4c58-425d-bdcb-8dd9bd41b713	2025-07-23	Warnings	Exact identifier application number: M017
Whipped Butter SPF 50	ZINC OXIDE	Bloomeffects, Inc	374b62d8-e012-591f-e063-6294a90aef93	2025-07-23	Warnings	Exact identifier application number: M017
Game On Xtreme	MENTHOL, UNSPECIFIED FORM	Natural Essentials Inc.	5a1b6192-d537-42b3-add8-22c63e7c986c	2025-07-23	Warnings	Exact identifier application number: M017

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
98PI200987	LIDOCAINE	137-58-6	LIDOCAINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1291672	lidocaine 4 % Topical Gel	PSN	7f96e980-891e-743d-e053-2a91aa0aea5f	5
1651001	Topicaine 4 % Topical Gel	PSN	7f96e980-891e-743d-e053-2a91aa0aea5f	5
1651001	lidocaine 0.04 MG/MG Topical Gel [Topicaine]	SBD	7f96e980-891e-743d-e053-2a91aa0aea5f	5
1291672	lidocaine 0.04 MG/MG Topical Gel	SCD	7f96e980-891e-743d-e053-2a91aa0aea5f	5
1291672	lidocaine 4 % Topical Gel	SY	7f96e980-891e-743d-e053-2a91aa0aea5f	5
1651001	Topicaine 4 % Topical Gel	SY	7f96e980-891e-743d-e053-2a91aa0aea5f	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
63135-312-04	63135031204	113 g in 1 TUBE (63135-312-04)	113 g	2003-04-20	0000-00-00	No	No	Current
63135-312-13	63135031213	1 TUBE in 1 BOX (63135-312-13) / 10 g in 1 TUBE	1 tube	2003-04-20	0000-00-00	No	No	Current
63135-312-30	63135031230	1 TUBE in 1 BOX (63135-312-30) / 30 g in 1 TUBE	1 tube	2003-04-20	0000-00-00	No	No	Current